Skip to main content
Log in

Selective gene therapy for proliferative disorders: Sense and antisense

  • News & Views
  • Published:

From Nature Medicine

View current issue Submit your manuscript

Targeting antisense oligonucleotides to c-Raf kinase slows the proliferation of tumor xenografts in mice (pages 668–675).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Ross, R. The pathogenesis of atherosclerosis, a perspective for the 1990's. Nature 362, 801–809 (1993).

    Article  CAS  Google Scholar 

  2. Ludwig, S. & Rapp, U.R. Cascading towards vascular disorder gene therapy. Nature Med. 1, 513–515 (1995).

    Article  CAS  Google Scholar 

  3. Krontiris, TG. Oncongens. New Engl. J. Med. 5, 303–306 (1995).

    Article  Google Scholar 

  4. Kohl, N.E. et al. Selective inhibition of ras-dependent transformation by a farnesyltransferase inhibitor. Science 260, 1934–1937 (1993).

    Article  CAS  Google Scholar 

  5. Indolfi, C. et al. Inhibition of cellular ras prevents smooth muscle cell proliferation after vascular injury in vivo. Nature Med. 1, 541–545 (1995).

    Article  CAS  Google Scholar 

  6. Wagner, R.W. The state of the art in antisense research. Nature Med. 1, 1116–1118 (1995).

    Article  CAS  Google Scholar 

  7. Stein, C.A. Does antisense exist? Nature Med. 1, 1119–1121 (1995).

    Article  CAS  Google Scholar 

  8. Monia, B.P. et al. Antitumor activity of a phosphorothioate antisense oligodeoxynucleotide targeted against c-raf kinase. Nature Med. 2, 668–675 (1996)

    Article  CAS  Google Scholar 

  9. Holt, J.T. et al. A ‘senseless’ immune response to DNAs. Nature Med. 1, 407–408 (1995).

    Article  CAS  Google Scholar 

  10. Yokozaki, H. et al. Unhydrolyzable analogue of adenosise 3′-5′-monophosphate demonstrating growth inhibition and differentiation in human cancer cells. Cancer Res. 52, 2504–2508 (1992).

    CAS  PubMed  Google Scholar 

  11. Grieco, D. et al. Requirement for cAMP-PKA pathway activation by M phase-promoting factor in the transition from mitosis to interphase. Science 271, 1718–1722 (1996).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Indolfi, C., Chiariello, M. & Avvedimento, E. Selective gene therapy for proliferative disorders: Sense and antisense. Nat Med 2, 634–635 (1996). https://doi.org/10.1038/nm0696-634

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm0696-634

  • Springer Nature America, Inc.

This article is cited by

Navigation